What is the best US healthcare services industry area to invest in, assuming I want to invest in a company that is profitable but under $10M of EBITDA, and I'm not interested in pharma, medical devices, or pure health tech?

Sonar Pro

Vote: Behavioral Health

I maintain my vote for **Behavioral Health (A)** as the best investment area. PwC explicitly flags 'early signs of activity in... behavioral health,' signaling stalled portfolios are trading—perfect for sub-$10M EBITDA platforms in this fragmented sector[3]. KPMG reinforces with 'behavioral health... attracted increased PE interest,' driven by demographics and outpatient demand[8]. These 2026-specific sources confirm momentum for small, profitable operators ripe for roll-ups, excluding pharma/devices/tech. Other arguments fail to sway me. DSOs (E, Grok) are competitive and 'picked-over'[Claude], with dental noted alongside but secondary to BH's 'early trading' signals[3]. PT (D, Kimi) lacks cited PE focus or small-scale mentions, trailing BH's explicit tailwinds. PPM (C) shows 'renewed movement' but at larger-scale valuation gaps[3]. Low capex/recurring revenue apply broadly, but BH uniquely combines supply shortages, parity laws, and PE validation[3][8][Claude/GPT/Gemini]. No model changed my view; others reinforce A's fragmentation, demand, and 2026 trading activity over alternatives' risks (e.g., ASC capex, lab reimbursement[1][3]).

GPT-5.4

Vote: Behavioral Health

I’m maintaining A: Behavioral Health. The core fit with the target profile remains strongest here: profitable sub-$10M EBITDA businesses, low capex, strong secular demand, and a highly fragmented provider base. That combination is unusually attractive in the lower middle market, where capital efficiency and room for operational scaling matter more than theoretical market size. The pro-D argument for Specialized Physical Therapy is thoughtful, especially on low capital intensity and fragmentation. But PT is still more exposed to referral leakage, therapist labor constraints, and payer-driven visit/utilization pressure. Even specialized niches can be harder to differentiate at scale than strong behavioral health platforms with real clinical programs and payer relationships. The pro-E argument for DSOs is less compelling for this specific entry point. Dental is a proven consolidation category, but it is also more competitive, more intermediated, and in many subsegments more sensitive to consumer discretionary demand than behavioral health. The “best” area is not just the one with historical roll-up success; it is the one with the best combination of runway, fragmentation, and less picked-over small-platform supply. Behavioral health still has the most compelling demand-supply imbalance of the options presented. That shortage supports sustained utilization and creates multiple paths to value creation: de novos, clinician recruitment, service-line expansion, and tuck-in M&A. For a sub-$10M EBITDA investor, that is exactly the kind of market structure you want. Yes, execution risk is real—especially around clinician retention, compliance, and reimbursement mix. But compared with ASCs, labs, urgent care, and many PPM models, behavioral health still offers the best mix of tailwinds, capital efficiency, and scalable scarcity value. So my final vote stays with A.

Grok 4.1 Fast

Vote: Dental Support Organizations

I maintain my vote for Dental Support Organizations (E) as the superior investment. While Behavioral Health (A) arguments highlight demand and fragmentation, they overlook critical risks: acute clinician shortages (psychologists/therapists face 30%+ vacancy rates per APA data), reimbursement volatility (Medicaid cuts in multiple states), and state-specific licensure barriers that hinder seamless roll-ups. These issues cap scalability for sub-$10M platforms, as noted in my initial thesis and echoed indirectly by Kimi K2.5. DSOs, conversely, thrive on abundant dentists (200k+ independents), 30-40% margins from recession-proof cash-pay services (cosmetics/cleanings up 15% YoY), and minimal regulatory hurdles. Proven consolidators like Heartland demonstrate 10-15x exit multiples with low execution risk. Aging demographics and aesthetic trends ensure 5-7% organic growth > GDP. Physical Therapy (D) is solid but faces commoditization and lower differentiation vs. DSO niches. ASCs (B) demand high capex; PPM (C) battles payer consolidation. No arguments sufficiently rebut DSOs' stability and tailwinds—BH hype ignores execution pitfalls for small platforms.

Gemini 3.1 Pro

Vote: Behavioral Health

I am maintaining my vote for Behavioral Health (A). While Kimi K2.5 makes a fair point regarding Specialized Physical Therapy (D) and Grok 4.1 Fast argues for Dental Support Organizations (E), both sectors have distinct drawbacks for a sub-$10M EBITDA platform. DSOs are notoriously 'picked over' and highly consolidated at the top by massive PE-backed players like Heartland and Aspen Dental. Entering the DSO space with a sub-$10M platform means you will face fierce competition for tuck-in acquisitions, driving up multiples and squeezing your return profile. Additionally, Physical Therapy is currently facing persistent headwinds from Medicare reimbursement rate cuts, which compresses margins. In contrast, Behavioral Health is experiencing the exact opposite reimbursement dynamic: commercial rates are generally increasing as payers realize that treating mental health drastically reduces overall medical costs (e.g., fewer ER visits). The clinician shortage that other models pointed out as a weakness in behavioral health is actually a protective moat; a well-run platform that centralizes credentialing, minimizes administrative burden, and offers flexible (or hybrid) work environments will attract talent and win market share. Behavioral health remains the most fragmented, capital-light sector with the strongest secular tailwinds, making it the premier choice for scaling a lower-middle market healthcare services platform.

Claude Opus 4.6

Vote: Behavioral Health

I'm maintaining my vote for Behavioral Health after careful consideration of all arguments presented. **Why the competing arguments didn't change my mind:** Kimi K2.5's case for Specialized Physical Therapy (D) is reasonable — low capital intensity and fragmentation are real advantages. However, PT faces significant reimbursement pressure from Medicare (which has cut PT reimbursement rates repeatedly), and the market is increasingly commoditized with large players like ATI and USPH already consolidating aggressively. The 'specialized niche' angle is interesting but narrows the addressable market considerably, making it harder to build a scalable platform. Grok's case for Dental Support Organizations (E) highlights real strengths — high margins, recurring revenue, and proven roll-up economics. However, DSOs have become one of the most crowded PE investment themes in healthcare services. Entry multiples have inflated significantly (the 10-15x EBITDA multiples Grok cites actually work *against* you as a buyer). Finding a sub-$10M EBITDA DSO platform at attractive valuations is increasingly difficult because every PE fund is chasing this space. Behavioral health, while gaining attention, still has more runway before saturation. **The final case for Behavioral Health:** The consensus among four of six models (Claude, Sonar Pro, GPT-5.4, Gemini) reflects a genuine analytical convergence, not groupthink. Behavioral health uniquely combines: (1) the strongest secular demand tailwinds in all of healthcare services, (2) extreme fragmentation with thousands of sub-$5M revenue targets, (3) minimal capital intensity — even lower than PT since you literally need an office and a clinician, (4) improving reimbursement dynamics rather than compressing ones, and (5) strategic buyer interest from health systems and national platforms that creates a clear exit path with multiple expansion. The clinician shortage concern raised by Kimi is real but manageable — it actually creates a moat for platforms that solve recruitment and retention well, and telehealth delivery models have expanded the available clinician pool geographically. For a profitable sub-$10M EBITDA platform, Behavioral Health offers the best combination of growth, margins, consolidation opportunity, and exit optionality.

Kimi K2.5 (changed mind)

Vote: Behavioral Health

I previously advocated for Specialized Physical Therapy (D), but I am now convinced that Behavioral Health (A) offers a superior risk-adjusted return for sub-$10M EBITDA platforms. While specialized PT niches are defensible, the sector faces persistent Medicare reimbursement pressure and commoditization risk in generalist settings that limit scalability. Behavioral Health presents even lower capital intensity than PT—requiring virtually no equipment beyond standard office fixtures—translating to exceptional free cash flow conversion critical for smaller platforms. The supply-demand imbalance is more acute in BH, with the Mental Health Parity Act driving sustained reimbursement improvements rather than the compression seen in PT. The fragmentation across thousands of independent practices offers abundant roll-up opportunities at attractive entry multiples (4-6x). Critically, the clinician shortage I previously viewed as a liability actually strengthens the platform thesis: consolidators can provide superior credentialing infrastructure, billing support, and career pathways that individual practices cannot match, enabling faster de novo growth and retention. Combined with recession-resistant demand and expanding insurance coverage, Behavioral Health provides the optimal combination of capital efficiency, fragmentation, and secular tailwinds.

Final Summary

The AI Roundtable overwhelmingly identified Behavioral Health as the premier sub-$10M EBITDA investment, citing its rare combination of low capital requirements and rising reimbursement rates. While Kimi K2.5 initially favored specialized physical therapy, they were ultimately swayed by Claude Opus 4.6 and Gemini 3.1 Pro, who argued that the sector's chronic clinician shortages actually create a protective 'moat' for organized platforms. Grok 4.1 Fast remained the lone dissenter, holding firm on the belief that the dental sector’s 40% margins and 'recession-proof' cash services offer more stability than the 'hype' of behavioral health.

Majority chose "Behavioral Health" after discussion (5/6). Final vote: Behavioral Health: 5, Dental Support Organizations: 1

Strongest Arguments

• Behavioral Health: The acute clinician shortage in behavioral health serves as a protective moat; a well-run platform that centralizes credentialing and billing will attract talent and win market share where independent providers fail.
• Specialized Physical Therapy: Specialized niches like pelvic health or neuro-rehab defy commoditization and command premium cash-pay rates with lower capital intensity than surgery centers.
• Dental Support Organizations: Dental practices offer 30-40% margins from recurring, recession-resistant cash services like checkups and cosmetics, with far fewer regulatory hurdles than physician practices.

Key Turning Points

• Claude Opus 4.6 and Gemini 3.1 Pro successfully argued that Dental (E) is 'picked over' and crowded, diminishing its attractiveness for new sub-$10M platforms.
• The group reframed the 'clinician shortage' in mental health from a risk to a strategic advantage for consolidators.
• Kimi K2.5 abandoned the Physical Therapy position after conceding that Medicare reimbursement pressure made Behavioral Health a superior risk-adjusted bet.